All In Biotech

Free tool

FAERS Monitor: Sandostatin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019667 or its brand name (Sandostatin, Octreotide Acetate). Reports on generic versions are filed under their own applications.

Reports

9,636

Serious

7,955

83% of reports

Hospitalization

3,835

Death reported

1,880

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea2,155
  • fatigue1,847
  • blood pressure increased1,658
  • nausea1,529
  • blood pressure systolic increased1,409
  • malaise1,232
  • abdominal pain1,227
  • death1,219
  • pain1,197
  • injection site pain1,138
  • asthenia1,064
  • weight decreased1,043
  • dizziness1,032
  • malignant neoplasm progression1,026
  • vomiting1,019

Reports by year received

View as table
YearReports
2004111
2005101
2006119
2007102
2008144
2009187
2010291
2011319
2012346
2013255
2014372
2015559
2016531
2017649
2018795
20191,050
20201,100
2021602
2022561
2023526
2024402
2025271
2026243

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,523 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure systolic increasedSignal1,409169.9161.6219,581
blood pressure increasedSignal1,65823.922.936,258
malignant neoplasm progressionSignal1,02622.120.820,520
abdominal painSignal1,22711.611.011,905
weight decreasedSignal1,0438.27.76,631
injection site painSignal1,1388.17.77,181
diarrhoeaSignal2,1557.37.012,058
astheniaSignal1,0646.25.84,697
malaiseSignal1,2326.15.85,401
fatigueSignal1,8475.25.06,465
vomitingSignal1,0194.74.53,064
dizzinessSignal1,0324.54.32,892
painSignal1,1974.34.03,066
nauseaSignal1,5294.24.03,897
deathSignal1,2193.12.91,794

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.